期刊文献+

乳腺导管内增生性病变中ERα基因启动子甲基化的探讨

Study on the estrogen receptor- alpha promoter methylation in breast intraductal proliferative lesions
下载PDF
导出
摘要 目的:研究与乳腺浸润性导管癌风险密切相关的导管内增生性病变中ERα基因启动子区甲基化情况。方法:用甲基化特异性PCR研究140例乳腺导管内增生性病变(UDH 40例、ADH 63例、DCIS 37例)的ERα第1、3、4、5启动子甲基化情况。结果:55.0%(22/40)UDH出现ERα基因启动子甲基化,11.1%(7/63)ADH出现ERα基因启动子甲基化,43.2%(16/37)DCIS出现ERα基因启动子甲基化,三者间差异显著(P<0.05)。结论:ERα基因启动子甲基化在乳腺癌的发生发展中是动态变化的,也许其并非是所有分子亚型乳腺癌的始动因素,但这个过程对于细胞的生物学行为改变是非常重要的。 Objective:To discuss the promoter methylation of estrogen receptor -alpha in breast intraductal prolif-erative lesions which related to the risk of breast invasive ductal cancer.Methods:The methylation of ERαpromoter was investigated in genomic DNA of 140 breast intraductal proliferative lesions(40 cases of usual ductal hyperplasia, 63 cases of atypical ductal hyperplasia,37 cases of ductal carcinoma in situ).Results:ERαmethylation was observed in 43.2%(16 /37)ductal carcinoma in situ,which was significantly lower than in usual ductal hyperplasia(55.0%, 22 /40)and was significant higher than in 11.1%(7 /63)atypical ductal hyperplasia(P〈0.05).Conclusion:The methylation of ERαin breast carcinogenesis was characterized by constant change.Perhaps it was not the initiating factor in breast carcinogenesis of different molecular subtype,but it affected the biological behavior of cells.
出处 《现代肿瘤医学》 CAS 2016年第13期2042-2044,共3页 Journal of Modern Oncology
基金 国家自然科学基金资助项目(编号:81201886/H1617&81401143/H2501) 辽宁省博士科研启动基金项目(编号:20121126)
关键词 乳腺导管内增生性病变 ERΑ 甲基化 breast intraductal proliferative lesions methylation
  • 相关文献

参考文献21

  • 1Man YG,Tai L,Barner R,et al.Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features:Implications for tumor progression and invasion[J].Breast Cancer Res,2003,5(6):R231-241.
  • 2Dong F,Irshad H,Oh EY,et al.Computational pathology to discriminate benign from malignant intraductal proliferations of the breast[J].PLoS One,2014,9(12):e114885.
  • 3Costarelli L,Campagna D,Mauri M,et al.Intraductal proliferative lesions of the breast-terminology and biology matter:Premalignant lesions or preinvasive cancer[J]?Int J Surg Oncol,2012,2012:501904.
  • 4Dieci MV,Piacentini F,Dominici M,et al.Quantitative expression of estrogen receptor on relapse biopsy for ER-positive breast cancer:Prognostic impact[J].Anticancer Res,2014,34(7):3657-3662.
  • 5Knoop AS,Lnkholm AV,Jensen MB,et al.Estrogen receptor,Progesterone receptor,HER2 status and Ki67 index and responsiveness to adjuvant tamoxifen in postmenopausal high-risk breast cancer patients enrolled in the DBCG 77C trial[J].Eur J Cancer,2014,50(8):1412-1421.
  • 6Plotkin A,Volmar CH,Wahlestedt C,et al.Transcriptional repression of ER through hMAPK dependent histone deacetylation by class I HDACs[J].Breast Cancer Res Treat,2014,147(2):249-263.
  • 7Chattopadhyay S,Deo SV,Shukla NK,et al.Association of promoter methylation of ERα and ERβ with sporadic breast cancer-a study from North India[J].Tumour Biol,2014,35(8):7911-7919.
  • 8Martínez-Galán J,Torres-Torres B,Núez MI,et al.ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients[J].BMC Cancer,2014,14:59.
  • 9Lapidus RG,Nass SJ,Butash KA,et al.Mapping of ER gene CpG island methylation-specific polymerase chain reaction[J].Cancer Res,1998,58(12):2515-2519.
  • 10Ghofrani M,Tapia B,Tavassoli FA.Discrepancies in the diagnosis of intraductal proliferative lesions of the breast and its management implications:Results of a multinational survey[J].Virchows Arch.2006,449(6):609-616.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部